Patient P-02011

Synthetic patientMETA-24 · Day 176 · 65–74 · M · baseline S09Steering view · 3D Open companion preview

Therapy response

Favorable

Tolerance

Favorable

GI state

Deteriorating

Inflammatory state

Deteriorating

Nutritional resilience

Stable

Discontinuation risk

32%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S09
Day 37 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 37.

Primary contributors, last 14 days

Inflammatory activity+9
GI instability+8
Toxicity-4

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

16 min

improving · +2.9 vs previous 14 d

Sleep duration

Wearable

6.2 h

stable · -0.1 vs previous 14 d

Energy level

Daily log

5.5/10

improving · +0.4 vs previous 14 d

Steps

Wearable

2,659

stable · +57 vs previous 14 d

GI burden

Companion

31.6/100

improving · -3.4 vs previous 14 d

Adherence

Companion

93.6 %

improving · +4.0 vs previous 14 d

Sleep quality

Wearable

20.4/100

stable · -0.6 vs previous 14 d

Glucose, CGM daily mean

CGM

139 mg/dL

stable · -0.1 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 64 from the failing basin, 23 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -4.1 next day on high-intake days · n 19

Would not help

Keep ultra-processed low
GI +1.8 next day on high-intake days · n 19

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-4.1supporter · 95%
Ultra-processed food
+1.8detractor · 62%
Caffeine
-0.9no signal · 22%
Alcohol
-0.9no signal · 22%
Dietary fat load
+0.6no signal · 18%
Insoluble fibre
-0.6no signal · 15%
Simple carbohydrates
-0.5no signal · 15%
Histamine load
+0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Autonomic recovery ↓65
- WearableResting HR 75 bpm
- Wearable2,659 steps/day
- WearableShort sleep window
Inflammatory signalling ↑40
- DNAIL6 -174 variant raises baseline inflammatory tone
- WearableHRV 20 ms, trending down

DNA

Fictional pharmacogenomic panel

IL6 -174 G/C
Higher inflammatory tone
CYP2D6 Intermediate metabolizer
Expected exposure
GLP1R rs6923761 A
Altered receptor sensitivity

Microbiome

Shannon diversity 3.6 · butyrate capacity 69/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisNormal
Bifidobacterium longumLow
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 27 ms
Sleep: 6.6 h
Steps: 3,572
Resting HR: 75 bpm

Daily log: GI score 32, nutritional resilience 60, adherence 94.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
A 15-minute walk after lunch
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02483	37%	S06	BR-03	no change	64
P-02267	33%	S09	BR-03	no change	45
P-02087	30%	S01	BR-03	no change	40
P-02354	41%	S01	CR-01	improved	78
P-02491	44%	S09	DT-01	no change	65
P-02518	41%	S17	DT-01	improved	68
P-02462	40%	S12	DT-01	improved	65
P-02126	36%	S16	DT-01	improved	59
P-02235	35%	S14	DT-01	improved	50
P-02274	35%	S15	DT-01	improved	50
P-02417	35%	S18	DT-01	no change	55
P-02455	35%	S09	DT-01	improved	50